Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    The lived experience of juvenile idiopathic arthritis in young people receiving etanercept

    This study explores young people’s daily experiences of living with Juvenile Idiopathic Arthritis (JIA) and their thoughts, beliefs and feelings related to the biological drug Etanercept, prescribed as part of...

    P Livermore, D Eleftheriou, LR Wedderburn in Pediatric Rheumatology (2016)

  2. Article

    Open Access

    PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland

    E Moraitis, K Arnold, LR Wedderburn, CA Pilkington in Pediatric Rheumatology (2013)

  3. Article

    Open Access

    PReS-FINAL-1009: Antioxidant superoxide dismutase activity is paradoxically normal in juvenile systemic lupus erythematosus

    A Radziszewska, C Rowden, L Suffield, S Ursu, L Kassoumeri in Pediatric Rheumatology (2013)

  4. Article

    Open Access

    PReS-FINAL-1011: Can repeated T cell receptor stimulation lead to epigenetic reprogramming of the treg-specific demethylated region in human conventional T cells?

    Q Wu, D Bending, LR Wedderburn in Pediatric Rheumatology (2013)

  5. Article

    Open Access

    PReS-FINAL-1021: Further characterization of CD161+ regulatory t cells in health and disease

    CL Duurland, G Chain, RF O'Shaughnessy, AM Pesenacker in Pediatric Rheumatology (2013)

  6. Article

    Open Access

    PReS-FINAL-1002: Dissecting the dissociation of foxp3 and cd25 expression on cd4+ t cells in synovial fluid identifies three distinct subpopulations of human t regulatory cells present at the chronically inflamed site

    D Bending, AM Pesenacker, Q Wu, LR Wedderburn in Pediatric Rheumatology (2013)

  7. Article

    Open Access

    PReS-FINAL-1017: Antioxidant superoxide dismutase activity is elevated in jia but not associated with disease activity

    A Radziszewska, C Rowden, L Suffield, S Ursu, L Kassoumeri in Pediatric Rheumatology (2013)

  8. Article

    Open Access

    PReS-FINAL-1001: Lymphocytes from the inflamed joint of juvenile idiopathic arthritis patients express reduced levels of cd73 and have a functional defect in adenosine production

    S Botta Gordon-Smith, S Eaton, S Ursu, H Moncrieffe in Pediatric Rheumatology (2013)

  9. Article

    Open Access

    PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease

    E Moraitis, S Tansley, K Arnold, ZE Betteridge, H Gunawardena in Pediatric Rheumatology (2013)

  10. Article

    Open Access

    PReS-FINAL-2135: Analysis of the HLA region in a large cohort of juvenile idiopathic arthritis cases identifies independent effects at HLA-DRB1

    A Hinks, J Cobb, B Han, MC Marion, M Sudman, P Martin, J Bohnsack in Pediatric Rheumatology (2013)

  11. Article

    Open Access

    Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study

    H Moncrieffe, D Holzinger, S Ursu, F Patrick, L Kassoumeri in Pediatric Rheumatology (2011)

  12. Article

    Open Access

    Comparison of data from the juvenile dermatomyositis national (UK & Ireland) cohort biomarker study and repository for idiopathic inflammatory myopathies with a survey of current practice throughout the UK and Ireland

    N Martin, LR Wedderburn, JE Davidson, L Beard, CA Pilkington in Pediatric Rheumatology (2011)

  13. Article

    Open Access

    Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate

    S Ursu, H Moncrieffe, H Varsani, RHB Hamaoui, L Beard in Pediatric Rheumatology (2011)

  14. Article

    Open Access

    Myeloid cells which secrete S100 proteins in juvenile dermatomyositis may contribute to disease activity

    H Varsani, H Wittkowski, J Roth, J Holton, LR Wedderburn in Pediatric Rheumatology (2008)

  15. Article

    Open Access

    15.3 Agreement between parent and adolescent assessment of disability, pain and well-being: results from the Childhood Arthritis Prospective Study (CAPS)

    SD Lal, N Adib, LR Wedderburn, J Gardner-Medwin, H Foster in Pediatric Rheumatology (2008)

  16. Article

    Open Access

    Association between IL2RA and juvenile idiopathic arthritis (JIA) disease severity at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study (CAPS)

    KL Hyrich, SD Lal, A Hinks, LR Wedderburn, J Gardner-Medwin in Pediatric Rheumatology (2008)

  17. Article

    Open Access

    An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept

    P Livermore, P Woo, LR Wedderburn in Pediatric Rheumatology (2008)

  18. Article

    Open Access

    14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?

    PJ Hunter, N **a, K Nistala, A Eddaoudi, M Hubank, LR Wedderburn in Pediatric Rheumatology (2008)

  19. Article

    Open Access

    Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)

    SP Hirani, L Kassoumeri, K Mulligan, N Ruperto, P Woo in Pediatric Rheumatology (2008)

  20. Article

    Open Access

    7.2 Interleukin-17 (IL-17) secreting cells in synovial fluid express the "Th17" master transcription factor RORC and their numbers correlate with CCL20 levels within the joint

    K Nistala, P Hunter, E Sala-Soriano, J Diss, LR Wedderburn in Pediatric Rheumatology (2008)

previous disabled Page of 2